Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals Stock Forecast

Stock Price Forecast

The 6 analysts that cover Tarsus Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $89, which forecasts a 44.83% increase in the stock price over the next year. The lowest target is $51 and the highest is $105.

Price Target: $89 (+44.83%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$51	$89	$100	$105
Change	-17.01%	+44.83%	+62.73%	+70.87%

* Price targets were last updated on Feb 25, 2026.

Analyst Ratings

The average analyst rating for Tarsus Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	4	4	4	4	2
Buy	3	4	4	4	4	3
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	9	9	9	9	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Francois Brisebois Oppenheimer	Oppenheimer	Buy Maintains $95 → $105	Buy	Maintains	$95 → $105	+70.87%	Feb 25, 2026
Eddie Hickman Guggenheim	Guggenheim	Strong Buy Maintains $87 → $90	Strong Buy	Maintains	$87 → $90	+46.46%	Feb 25, 2026
Glen Santangelo Barclays	Barclays	Buy Initiates $100	Buy	Initiates	$100	+62.73%	Dec 9, 2025
Graig Suvannavejh Mizuho	Mizuho	Buy Initiates $100	Buy	Initiates	$100	+62.73%	Nov 20, 2025
Eddie Hickman Guggenheim	Guggenheim	Strong Buy Maintains $84 → $87	Strong Buy	Maintains	$84 → $87	+41.58%	Nov 5, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

706.04M

Increased by 56.43%

from 451.36M

Revenue Next Year

919.17M

Increased by 30.19%

from 706.04M

EPS This Year

-0.61

from -1.59

EPS Next Year

3.21

from -0.61

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	57.03M	25.82M	17.45M	182.95M	451.36M	706.04M	919.17M
Revenue Growth	-	-54.73%	-32.42%	948.62%	146.71%	56.43%	30.19%
EPS	-0.67	-2.52	-4.62	-3.07	-1.59	-0.61	3.21
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	19.12
No. Analysts	-	-	-	-	-	11	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	755.8M	1.0B
Avg	706.0M	919.2M
Low	668.1M	833.0M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	67.4%	47.0%
Avg	56.4%	30.2%
Low	48.0%	18.0%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	0.35	4.88
Avg	-0.61	3.21
Low	-0.88	1.91

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.